Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients

Launched by TERESA MATEU CAMPOS · Aug 7, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the long-term benefits of a treatment called focused extracorporeal shock wave therapy (fESWT) for stroke patients who have a condition known as spastic equinus foot. This condition causes tightness in the calf muscles, making it difficult to walk properly. The trial aims to find out whether having three sessions of this therapy is more effective in reducing muscle tightness and improving walking ability than just one session.

To participate in this study, individuals need to be at least 18 years old and have experienced a stroke at least six months prior. They should also be able to walk with or without assistance, but they cannot have certain issues like severe joint stiffness or cognitive problems. If eligible, participants can expect to receive the therapy and then will be monitored to see how their muscle tightness and walking ability improve over time. This trial is currently recruiting participants of all genders aged 65 to 74, so if you or someone you know fits this description, it might be worth considering getting involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater than 18 years old
• • Time from stroke (ischemic o hemorrhagic) onset of at least 6 months
• • Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score
• • Ability to walk alone with or without aids
• Exclusion Criteria:
• • Fixed ankle joint contracture
• • Severe medical problems
• • Treatment of the affected leg with botulinum toxin in the las 6 months
• • Cognitive impairment